From Regulation to Innovation: Lilly’s Strategic Evolution in the Wake of IVDR

• The evolution of the Dx team in a pharma company
• How IVDR prompted deeper integration between Regulatory Affairs, Quality, Clinical, and Laboratory teams
• Which changes to the IVDR could streamline clinical trials in the EU

Speakers:

Nicole Chaves Petronzi

Senior Director, Global Regulatory Affairs Diagnostics

Eli Lilly & Co.